Illoprost (Ventavis) is indicated for the treatment of which condition?

Illoprost, marketed under the brand name Ventavis, is specifically indicated for the treatment of pulmonary arterial hypertension (PAH). This condition is characterized by elevated blood pressure in the pulmonary arteries, which can lead to serious complications such as heart failure if left untreated. Illoprost works as a prostacyclin analog, promoting vasodilation and thereby improving blood flow in the pulmonary circulation.

The drug's effectiveness in PAH is directly related to its mechanism of action, which helps reduce the workload on the heart and improves exercise capacity and overall quality of life for patients. This distinct indication sets it apart from conditions like chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease, which are treated with different therapeutic approaches and medications.